‘Lupin has gained significant momentum towards development of biosimilar products with primary focus on regulated markets’ Read more
‘R&D continues to be the key driver for sustained growth’—Kushal Suri, Head International Business Development, Morepen Laboratories Read more
Preparing Pharma For the Future: How Learning Management Systems are Bridging the Skill Gap Read more
Our efficient screening processes help our partners to reach their goal faster — Dopesh Raja Mulakala, Managing Director, Vanta Bio Science and economically Read more
By 2030, we want to treat one in five cancer patients in India: Lara Bezerra, MD Roche India Read more